Disease-specific overall survival in endometrioid ovarian

Disease-specific overall survival in endometrioid ovarian carcinoma

Disease-specific overall survival in endometrioid ovarian carcinoma

Treatment Patterns and Outcomes Among Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States

Pretreatment with LCK Inhibitors Chemosensitizes Cisplatin-Resistant Endometrioid Ovarian Tumors

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome

NEw developments IN gynecological Oncology - ppt download

PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair

Overall survival curves for patients with advanced-stage epithelial

The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas

Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer

Diagnostics, Free Full-Text

From New Molecular Insights to New Treatment Options in Endometrial Cancer

Prognosis of ovarian clear cell cancer compared with other epithelial cancer types: A population‑based analysis